|
|
Volumn 20, Issue 2, 2008, Pages 183-189
|
|
The MAPK pathway in melanoma
|
|
Author keywords
BRAF; MAPK; Melanoma
|
|
Indexed keywords
17 DEMETHOXY 17 (2 DIMETHYLAMINOETHYLAMINO)GELDANAMYCIN;
2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE;
5 (4 BROMO 2 CHLOROANILINO) 4 FLUORO 1 METHYL 1H BENZIMIDAZOLE 6 CARBOHYDROXAMIC ACID 2 HYDROXYETHYL ESTER;
ANTINEOPLASTIC AGENT;
B RAF KINASE;
BEVACIZUMAB;
CAPECITABINE;
CARBOPLATIN;
CHIR 265;
DACARBAZINE;
IMATINIB;
MITOGEN ACTIVATED PROTEIN KINASE;
N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE;
PACLITAXEL;
PLEXIKKON;
PLX 4032;
SORAFENIB;
TANESPIMYCIN;
TEMOZOLOMIDE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
BILE DUCT CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CELL CYCLE;
CELL SURFACE;
CELL SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
COMBINATION CHEMOTHERAPY;
DRUG EFFICACY;
DRUG INHIBITION;
ENZYME ACTIVATION;
ESOPHAGUS CARCINOMA;
HEAD AND NECK CANCER;
HUMAN;
LUNG CANCER;
MELANOMA;
MONOTHERAPY;
MUTATIONAL ANALYSIS;
MYELOID LEUKEMIA;
NONHODGKIN LYMPHOMA;
NONHUMAN;
OVARY TUMOR;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVIEW;
SOMATIC MUTATION;
STOMACH CANCER;
SUN EXPOSURE;
THYROID CARCINOMA;
UPREGULATION;
HUMANS;
MAP KINASE SIGNALING SYSTEM;
MELANOMA;
MITOGEN-ACTIVATED PROTEIN KINASES;
|
|
EID: 39849108181
PISSN: 10408746
EISSN: None
Source Type: Journal
DOI: 10.1097/CCO.0b013e3282f5271c Document Type: Review |
|
Times cited : (223)
|
|
References (86)
|
